期刊文献+

子痫前期患者血清VEGF、TNF-α和sFlt-1水平的变化及意义 被引量:1

Changes and significance of serum VEGF, TNF-α and sFlt-1 in preeclampsia pregnant women
下载PDF
导出
摘要 目的探讨子痫前期患者血清中血管内皮生长因子(VEGF)、肿瘤坏死因子-α(TNF-α)及其可溶性血管内皮生长因子受体(lsFlt-1)的水平及意义。方法采用酶联免疫吸附试验法测定30例重度子痫前期疾病患者血清VEGF、TNF-α及其sFlt-1水平,并与正常孕妇30例对照比较。结果重度子痫前期患者血清VEGF水平显著低于对照组,而血清TNF-α、sFlt-1水平明显高于对照组,差异均有统计学意义(均P<0.05)。重度子痫前期患者血清VEGF水平与TNF-α及sFlt-1均呈负相关(均P<0.05)。结论VEGF、TNF-α、sFlt-1参与子痫前期的发病,VEGF与TNF-α、sFlt-1的相互调节在子痫前期的发病机制中可能起一定作用。 【Objective】 To research the significance and level of serum VEGF, TNF -αand sFlt -1 in preeclampsia pregnant women.【Methods】To adopt the way of the enzyme-linked immunosorbent assay (ELISA) to test 30 cases of patients with severe preeclampsia and 30 cases of healthy pregnant women in serum VEGF, TNF- αand sFlt-1 level , and to make their comparison. 【Results】Maternal serum levels of VEGF in women with severe preeclampsia (SPE) was significantly lower than controls (P 0.05). The serum levels of TNF-α and sFlt-1 in women with SPE were obviously higher than controls (both P 0.05). There was significant negative correlation between both TNF-α and sFlt-1 and VEGF (both P 0.05). 【Conclusion】VEGF, TNF-α and sFlt-1 may contribute to the pathology of preeclampsia, VEGF may play a role in the pathogenesis of preeclampsia by the regulation of sFlt-1 and TNF-α.
作者 肖淑彬
出处 《中国医学工程》 2009年第4期253-255,共3页 China Medical Engineering
关键词 子痫前期 血管内皮生长因子 肿瘤坏死因子-α 可溶性血管内皮生长因子受体l preeclampsia vascular endothelial growth factor (VEGF) tumor necrosis factor-alpha (TNF-α) soluble vascular endothelial growth factor receptors 1 (sFlt-1)
  • 相关文献

参考文献7

  • 1FREEMAN DJ, MCMANUS F, BROWN EA, et al. Short-and long-term changes in plasma inflammatory markers associated with preeclampsia [J]. Hypertension, 2004, 44(5):708-714.
  • 2欧阳艳琼,陈汉平,陈惠祯,蒋荣珍,沈红玲.妊娠期高血压疾病患者血清脂联素、瘦素水平的变化及其临床意义的研究[J].中国现代医学杂志,2007,17(6):697-700. 被引量:23
  • 3PERACOLI JC, RUDGE MV, PERACOLI MT. Tumor necrosis factor-alpha in gestation and puerperium of women with gestational hypertension and preeclampsia [J]. Am J Reprod Immunol, 2007, 57(3): 177-185.
  • 4ROBERTS JM, COOPER DW. Pathogenesis and genetics of oreeclampsia[J]. Lancet, 2001, 357(1): 53-56.
  • 5林其德.妊娠高血压综合征病因学研究进展与展望[J].中华妇产科杂志,2003,38(8):471-473. 被引量:138
  • 6MAYARD SE, MIN JY, MERCHAN J, et al. Excess placental soluble fms-like tyrosine kinase 1 (sFltl) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia [J]. J Clin Invest, 2003, 11"1(5): 649-658.
  • 7LEVINE RJ, MAYNARD SE, QIAN C, et al. Circulating angiogenic factors and the risk of preeclampsia [J]. N Engl J Med, 2004, 350(11): 672-683.

二级参考文献3

共引文献159

同被引文献9

引证文献1

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部